IL10 and multiminicore myopathy: Upon stimulation with phorbol myristate acetate (PMA), the number of IL-10-positive (CD11b+) PBMNCs from patients with MMD (0.68%) did not change, but there was a significant increase in the number of IL-10-positive PBMNCs from controls (1.33%)(p < 0.05; Fig. 6).